Literature DB >> 26731400

Correction: The Human Myotrophin Variant Attenuates MicroRNA-Let-7 Binding Ability but Not Risk of Left Ventricular Hypertrophy in Human Essential Hypertension.

.   

Abstract

Entities:  

Year:  2016        PMID: 26731400      PMCID: PMC4701401          DOI: 10.1371/journal.pone.0146735

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
Dr. Zhidong Ye is not included in the author byline. He should be listed as the seventh author and affiliated with the Department of Cardiovascular Surgery, China-Japan Friendship Hospital, Beijing, China. The contributions of this author are as follows: Performed the experiments, analyzed the data, and contributed reagents/materials/analysis tools. The incorrect version of Fig 3 appears in the paper. Please see the correct version of Fig 3 here. The publisher apologizes for the error.
Fig 3

Let-7c suppresses the protein expression level of myotrophin in vitro cellular model.

Cardiomyocytes were infected with PremiR miRNA precursor or Anti-miR miRNA inhibitor of let-7c (A and B). Myotrophin expression was analyzed by immunoblot 48 h after infection. *p < 0.05.

Let-7c suppresses the protein expression level of myotrophin in vitro cellular model.

Cardiomyocytes were infected with PremiR miRNA precursor or Anti-miR miRNA inhibitor of let-7c (A and B). Myotrophin expression was analyzed by immunoblot 48 h after infection. *p < 0.05.
  1 in total

1.  The Human Myotrophin Variant Attenuates MicroRNA-Let-7 Binding Ability but Not Risk of Left Ventricular Hypertrophy in Human Essential Hypertension.

Authors:  Yuyao Wang; Jingzhou Chen; Weihua Song; Yuxuan Wang; Yu Chen; Yu Nie; Zhidong Ye; Rutai Hui
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.